C&R Research Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
C&R Research has a total shareholder equity of ₩45.0B and total debt of ₩5.0B, which brings its debt-to-equity ratio to 11.1%. Its total assets and total liabilities are ₩79.5B and ₩34.5B respectively. C&R Research's EBIT is ₩5.7B making its interest coverage ratio -594.6. It has cash and short-term investments of ₩13.0B.
Belangrijke informatie
11.1%
Verhouding schuld/eigen vermogen
₩5.00b
Schuld
| Rente dekkingsratio | -594.6x |
| Contant | ₩13.01b |
| Aandelen | ₩44.97b |
| Totaal verplichtingen | ₩34.50b |
| Totaal activa | ₩79.46b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: A359090's short term assets (₩38.9B) exceed its short term liabilities (₩31.7B).
Langlopende schulden: A359090's short term assets (₩38.9B) exceed its long term liabilities (₩2.8B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: A359090 has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if A359090's debt to equity ratio has reduced over the past 5 years.
Schuldendekking: A359090's debt is well covered by operating cash flow (147.4%).
Rentedekking: A359090 earns more interest than it pays, so coverage of interest payments is not a concern.